`Matthew L. Fedowitz, Esq.
`Daniel R. Evans, Esq.
`MERCHANT & GOULD P.C.
`1900 Duke Street, Suite 600
`Alexandria, VA 22314
`Main Telephone: (703) 684-2500
`Main Facsimile: (703) 684-2501
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`
`
`BRECKENRIDGE PHARMACEUTICAL, INC.
`Petitioner
`
`
`
`v.
`
`
`
`NOVARTIS AG
`Patent Owner
`
`_____________________
`
`Case No. IPR2016-01103
`Patent No. 5,665,772
`_____________________
`
`
`
`PETITIONER’S TRANSMITTAL LETTER ACCOMPANYING
`SUBMISSION OF EXHIBIT 1030
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.6(e)(4)(ii) and the Board’s June 2, 2016 Order in
`
`IPR2016-00084 (Paper 13) and IPR2016-01059 (Paper 6), Petitioner Breckenridge
`
`Pharmaceutical, Inc. respectfully submits the following exhibit.
`
`Exhibit
`1030
`
`
`Description
`Transcript of June 1, 2016 Conference Call
`
`Respectfully submitted,
`
`
` /Matthew L. Fedowitz/
`B. Jefferson Boggs, Esq., Reg. No. 32,344
`Matthew L. Fedowitz, Esq., Reg. No. 61,386
`Daniel R. Evans, Esq., Reg. No. 55,868
`Merchant & Gould P.C.
`1900 Duke Street, Suite 600
`Alexandria, VA 22314
`jboggs@merchantgould.com
`mfedowitz@merchantgould.com
`devans@merchantgould.com
`Main Telephone: (703) 684-2500
`Main Facsimile: (703) 684-2501
`
`Counsel for Petitioner
`
`
`
`
`By:
`
`
`
`Date: June 7, 2016
`
`
`
`
`
`
`
`CERTIFICATION OF SERVICE
`
`Pursuant to 37 C.F.R. 42.6(e), I certify that on this 7th day of June, 2016,
`
`true and correct copies of the foregoing PETITIONER’S TRANSMITTAL
`
`LETTER ACCOMPANYING SUBMISSION OF EXHIBIT 1030 and
`
`EXHIBIT 1030 were served on the Patent Owner by serving via overnight
`
`delivery the correspondence address of record for the ’772 Patent and counsel for
`
`Novartis AG and via FedEx International Priority Novartis AG:
`
`Novartis Pharmaceutical Corporation
`Intellectual Property Department
`Attn: Peter J. Waibel, Esq. (Head of Patent Litigation)
`One Health Plaza 433/2
`East Hanover, NJ 07936-1080
`
`Novartis International AG
`Novartis Campus
`Attn: Alisa A. Harbin, Esq. (Head, Group Litigation and
`Intellectual Property)
`Forum 1-1.20
`Basel, CH-4002
`SWITZERLAND
`
`
`
`
`
`I also certify that on this 7th day of June, 2016, true and correct copies of
`
`the foregoing PETITIONER’S TRANSMITTAL LETTER
`
`ACCOMPANYING SUBMISSION OF EXHIBIT 1030 and EXHIBIT 1030
`
`were served by electronic mail on counsel for Novartis AG at the following
`
`email address:
`
`
`
`
`
`Nicholas N. Kallas (Reg. No. 32,530)
`Raymond R. Mandra (Reg. No. 34,382)
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`New York, NY 10104-3800
`ZortressAfinitorIPR@fchs.com
`
`
`
`Respectfully submitted,
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` /Matthew L. Fedowitz/
`B. Jefferson Boggs, Esq., Reg. No. 32,344
`Matthew L. Fedowitz, Esq., Reg. No. 61,386
`Daniel R. Evans, Esq., Reg. No. 55,868
`MERCHANT & GOULD P.C.
`1900 Duke Street, Suite 600
`Alexandria, VA 22314
`jboggs@merchantgould.com
`mfedowitz@merchantgould.com
`devans@merchantgould.com
`Main Telephone: (703) 684-2500
`Main Facsimile: (703) 684-2501
`
`Counsel for Petitioner
`
`
`June 7, 2016